These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 30300420)

  • 1. The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis.
    Khan AI; Levin A; Chao DL; DeRoeck D; Dimitrov DT; Khan JAM; Islam MS; Ali M; Islam MT; Sarker AR; Clemens JD; Qadri F
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006652. PubMed ID: 30300420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.
    Schaetti C; Weiss MG; Ali SM; Chaignat CL; Khatib AM; Reyburn R; Duintjer Tebbens RJ; Hutubessy R
    PLoS Negl Trop Dis; 2012; 6(10):e1844. PubMed ID: 23056660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.
    Khan IA; Saha A; Chowdhury F; Khan AI; Uddin MJ; Begum YA; Riaz BK; Islam S; Ali M; Luby SP; Clemens JD; Cravioto A; Qadri F
    Vaccine; 2013 Dec; 31(51):6058-64. PubMed ID: 24161413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh.
    Sarker AR; Islam Z; Khan IA; Saha A; Chowdhury F; Khan AI; Cravioto A; Clemens JD; Qadri F; Khan JA
    Vaccine; 2015 Sep; 33(38):4916-21. PubMed ID: 26232545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.
    Murray J; McFarland DA; Waldman RJ
    Bull World Health Organ; 1998; 76(4):343-52. PubMed ID: 9803585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis.
    Jeuland M; Cook J; Poulos C; Clemens J; Whittington D;
    Value Health; 2009 Sep; 12(6):899-908. PubMed ID: 19824189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of different strategies of oral cholera vaccination in bangladesh: a modeling study.
    Dimitrov DT; Troeger C; Halloran ME; Longini IM; Chao DL
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3343. PubMed ID: 25473851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
    Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
    Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the costs of cholera illness and cost-effectiveness of a single dose oral vaccination campaign in Lusaka, Zambia.
    Tembo T; Simuyandi M; Chiyenu K; Sharma A; Chilyabanyama ON; Mbwili-Muleya C; Mazaba ML; Chilengi R
    PLoS One; 2019; 14(5):e0215972. PubMed ID: 31150406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh.
    Khan AI; Khan IA; Siddique SA; Rahman A; Islam MT; Bhuiya MAI; Saha NC; Biswas PK; Saha A; Chowdhury F; Qadri F
    Hum Vaccin Immunother; 2019; 15(6):1302-1309. PubMed ID: 30261152
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential impact of reactive vaccination in controlling cholera outbreaks: an exploratory analysis using a Zimbabwean experience.
    Kim SY; Choi Y; Mason PR; Rusakaniko S; Goldie SJ
    S Afr Med J; 2011 Sep; 101(9):659-64. PubMed ID: 21920160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.
    Ali M; Qadri F; Kim DR; Islam T; Im J; Ahmmed F; Chon Y; Islam Khan A; Zaman K; Marks F; Clemens JD
    Int J Epidemiol; 2019 Aug; 48(4):1252-1261. PubMed ID: 30968110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.
    Qadri F; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Begum YA; Bhuiyan TR; Chowdhury MI; Uddin MJ; Khan JAM; Chowdhury AI; Rahman A; Siddique SA; Asaduzzaman M; Akter A; Khan A; Ae You Y; Siddik AU; Saha NC; Kabir A; Riaz BK; Biswas SK; Begum F; Unicomb L; Luby SP; Cravioto A; Clemens JD
    Lancet; 2015 Oct; 386(10001):1362-1371. PubMed ID: 26164097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing immunization schedules in endemic cholera regions: cost-effectiveness assessment of vaccination strategies for cholera control in Bangladesh.
    Zeng W; Cui Y; Jarawan E; Avila C; Li G; Turbat V; Bouey J; Farag M; Mutasa R; Ahn H; Sun D; Shen J
    Vaccine; 2021 Oct; 39(43):6356-6363. PubMed ID: 34579976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh.
    Khan AI; Islam MS; Islam MT; Ahmed A; Chowdhury MI; Chowdhury F; Siddik MAU; Clemens JD; Qadri F
    Vaccine; 2019 Feb; 37(6):827-832. PubMed ID: 30639459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost-benefit analysis of programmatic use of CVD 103-HgR live oral cholera vaccine in a high-risk population.
    Cookson ST; Stamboulian D; Demonte J; Quero L; Martinez de Arquiza C; Aleman A; Lepetic A; Levine MM
    Int J Epidemiol; 1997 Feb; 26(1):212-9. PubMed ID: 9126522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis.
    Naficy A; Rao MR; Paquet C; Antona D; Sorkin A; Clemens JD
    JAMA; 1998 Feb; 279(7):521-5. PubMed ID: 9480362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations around the introduction of a cholera vaccine in Bangladesh.
    Nelson CB; Mogasale V; Bari TI; Clemens JD
    Vaccine; 2014 Dec; 32(52):7033-6. PubMed ID: 24856784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh.
    Qadri F; Wierzba TF; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Asaduzzaman M; Akter A; Khan A; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Islam T; Chowdhury AI; Rahman A; Siddique SA; You YA; Kim DR; Siddik AU; Saha NC; Kabir A; Cravioto A; Desai SN; Singh AP; Clemens JD
    N Engl J Med; 2016 May; 374(18):1723-32. PubMed ID: 27144848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India.
    Ali M; Sur D; You YA; Kanungo S; Sah B; Manna B; Puri M; Wierzba TF; Donner A; Nair GB; Bhattacharya SK; Dhingra MS; Deen JL; Lopez AL; Clemens J
    Clin Infect Dis; 2013 Apr; 56(8):1123-31. PubMed ID: 23362293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.